SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about conference call

07 Feb 2026 Evaluate
Further to its letter dated February 06, 2026, intimating about the date of the Board of Directors Meeting to, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31, 2025. Eris Lifesciences has informed that pursuant to Regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Friday, February 13, 2026, at 05:30 pm IST. The details of the said call are attached and are also available on Company’s website.

The above information is a part of company’s filings submitted to BSE. 

Eris Lifesciences Share Price

1322.75 7.35 (0.56%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×